ACIP Recommendation for Use of CSL Influenza Vaccine
August 6, 2010
On Thuday, August 5, 2010, CDC's Advisory Committee on Immunization Practices (ACIP) met to discuss recommendations for use in the United States of seasonal influenza trivalent inactivated vaccine (TIV) [Afluria] manufactured by CSL Limited during 2010-11.